Haemonetics (NYSE:HAE) announced today that it agreed to sell its whole blood assets to GVS S.p.A for $67.1 million.

Alyx is designed to help optimize your bottom line with reduced labor and error related costs and the ability to increase collection of high value components.

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a ...

Apheresis machine for extracorporeal elimination of LDL cholesterol in patients with familial hypercholesterolemia, hyperlipoproteinemia (a), hyperfibrinogenemia, transplant vasculopathy.

Previous studies have suggested that leukocyte apheresis, which selectively removes about 65% of activated granulocytes and 55% of activated monocytes from peripheral blood, can improve IBD ...

Apheresis is the process of removing blood from a patient while using a special machine to separate the different components of blood. One or more components are removed to use in treatments or ...